Abstract
Cutting-edge infectious disease (ID) data on prevention of recurrent Clostridium difficile in high-risk patients and treatment of this conditionin children were presented, along with the impact of antibiotic stewardship programs and new HIV research, at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) and the 2014 IDWeek conference.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
